Search
forResearch 10 of 1000+
- Disease burden, clinical management and unmet treatment need of patients with moderate to severe alopecia areata; consensus statements, insights, and practices from CERTAAE (Central/Eastern EU, Russia, Türkiye AA experts) Delphi panel
- Global Burden of Skin Disease as Reflected in<i>Cochrane Database of Systematic Reviews</i>
- Real-world Burden of Disease and Clinical Characteristics of Alopecia Areata Among Adults in Brazil: Results from a Cross-sectional Survey
- Assessing the burden of dermatological diseases on work life from a gender perspective
- The Burden of Disease in Alopecia Areata: Canadian Online Survey of Patients and Caregivers
- Measuring the Burden of Disease in Korea Using Disability-Adjusted Life Years (2008–2020)
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Association between Androgenetic Alopecia and Psychosocial Disease Burden: A Cross-Sectional Survey among Polish Men
- Estimating the burden of skin diseases using patient‐reported daily time trade‐off as a measure of disease impact and unmet needs
- Global Burden of Alopecia Areata and Associated Diseases: A Trend Analysis From 1990 to 2021.
Community 3 of 23
- ‘Long term use of fin/dut may be associated with health risks including fatty liver disease, insulin resistance, type 2 diabetes, dry eye disease and potential kidney disease.’
- Pattern hair loss before the age of 35 is associated with higher chances of prostate cancer, cardiovascular diseases, and metabolic syndrome later in life
- Androgenetic alopecia is a skin disease: DHT-mediated skin disorders
Learn
— no results
Try a deeper search in learn →